• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gujarat Terce Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3500.0
  • ISIN : INE499G01013
49.15 -1 (-1.95%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    48.60

  • Today’s High

    51.00

  • Open

    51.00

  • Perv Close

    50.13

  • 52W Low

    45.15

  • 52W High

    94.90

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    36.47

  • Div & Yield %

    0.00

  • Book Value(₹)

    8.26

  • Debt-Equity Ratio

    -1.95

  • AGM Date

    01-Aug-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    36.47

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    7.42

  • BV (₹)

    8.30

  • Sales( ₹ in Cr.)

    50.20

  • NP (in Cr.)

    -0.99

  • NP Var(%)

    -505.0

  • Div%

    0.0

  • CPS (₹)

    -0.80

  • EPS (₹)

    -1.30

  • Traded Value (₹ in Lakhs)

    36.47

  • 52 Week High

    94.90

  • 52 Week Low

    45.15

  • Price BSE

    49.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    36.47

  • P/C Ratio

    -60.40

  • P/E Ratio

    -36.80

  • Price Vs.BV

    -1.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 50.20 47.97 46.78 40.13 25.18 37.54
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 50.20 47.97 46.78 40.13 25.18 37.54
Other Income 0.31 0.32 0.35 0.31 0.80 0.29
Stock Adjustments 0.38 -1.04 -1.65 2.63 0.26 0.37
Total Income 50.89 47.25 45.48 43.07 26.24 38.20
EXPENDITURE :            
Raw Materials 19.29 16.65 17.70 17.88 10.25 14.28
Power and Fuel Cost 0.15 0.17 0.11 0.16 0.10 0.10
Employee Cost 15.37 15.11 14.38 15.49 12.63 14.81
Other Manufacturing Expenses 0.55 0.22 0.44 1.58 0.93 1.07
Selling and Administration Expenses 11.26 13.44 14.57 5.97 3.93 6.02
Miscellaneous Expenses 0.06 0.07 0.10 0.56 0.37 0.95
Employee Benefit Expenses 15.37 15.11 14.38 15.49 12.63 14.81
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 46.69 45.67 47.29 41.65 28.20 37.24
Operating Profit 4.20 1.59 -1.81 1.42 -1.97 0.97
Interest 0.42 0.68 0.72 0.40 0.39 0.29
Gross Profit 3.78 0.91 -2.53 1.02 -2.36 0.68
Depreciation 0.38 0.37 0.36 0.28 0.18 0.24
Profit Before Tax 3.40 0.54 -2.89 0.74 -2.54 0.44
Current Tax 0.16 0.00 0.00 0.00 0.00 0.21
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.21 0.30 -1.22 -0.13 -0.01 -0.05
Reported Net Profit -0.98 0.24 -1.67 0.87 -2.52 0.28
Extraordinary Items 0.01 0.00 0.00 0.00 -0.18 0.00
Adjusted Net Profit -0.99 0.24 -1.67 0.87 -2.34 0.28
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -0.93 0.00
P & L Balance brought forward -2.23 -2.48 -0.80 -1.68 1.77 1.50
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -3.21 -2.23 -2.48 -0.80 -1.68 1.77
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -1.32 0.33 -2.25 1.18 -3.40 0.37
Earnings Per Share(Adj)-Unit Curr -1.32 0.33 -2.25 1.18 -3.40 0.37
Book Value 8.26 9.58 9.25 11.50 10.33 14.97
Book Value(Adj)-Unit Curr 8.26 9.58 9.25 11.50 10.33 14.97

Shareholding Pattern

  • Promoter Group

    37.03%

  • Public Share Holding

    62.97%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,075,900 14.50 1,075,900 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 7,500 0.10 7,500 1
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,664,327 22.43 1,664,327 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,747,727 37.03 2,747,727 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 111,513 1.50 109,913 26
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 58,270 0.79 58,270 28
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,295,204 17.45 1,294,904 33
Individuals holding nominal share capital up to Rs. 1 lakh 3,091,513 41.66 1,921,713 13,616
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 116,073 1.56 116,073 95
Sub Total 4,672,573 62.97 3,500,873 13,798
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 7,420,300 100.00 6,248,600 13,804

Company Background

Gujarat Terce Laboratories LtdPharmaceuticals - Indian - Formulations

  • Gujarat Terce Laboratories Ltd
  • BSE Code : 3500.0
  • ISIN : INE499G01013

  • Incorporation Year

    1985

  • Registered Office

    122/2 Ravi Estate
    Bileshwarpura Chhatral, Gandhinagar,
    Gujarat-382729

  • Telephone

    91-079-6663 3706

  • FAX

  • Chairman

    Natwarbhai P Prajapati

  • Managing Director

    Aalap Prajapati

  • Company Secretary

  • Auditor

    M A Shah & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Gujarat Terce Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Guj. Terce Labs. 49.15 50.50 50.20 -37.23 0.00
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10